Search
for
Sort by
Research 571–600 of 1000+
- Hair Loss in Women
- The Assessment and Management of Tinea Capitis in Children
- Secondary cicatricial and other permanent alopecias
- Skin manifestations of chronic kidney disease
- General practitioners’ knowledge and practices related to alopecia areata in Qassim region, Saudi Arabia
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Retinoids in Hair Disorders
- Case of alemtuzumab-related alopecia areata management in MS
- TREATMENT OF ACNE VULGARIS, OR EVERYTHING WE SHOULD KNOW ABOUT ISOTRETINOIN
- A rare case of pemphigus vulgaris in pregnancy
- Toxic Epidermal Necrolysis
- Serious Delayed Hair Toe Tourniquet Syndrome with Bone Erosion and Flexor Tendon Lesion
- Autoimmunity and clinical pathology amelioration in SLE by Dexamethasone primed Mesenchymal Stem Cell derived conditioned media
- SATU KASUS DERMATOSIS PUSTULAR SUBKORNEAL YANG DITERAPI DENGAN KORTIKOSTEROID
- Systemic immunotherapies
- Cutaneous Lupus Erythematosus
- Balding man.
- Acquired scalp alopecia. Part II: A review
- Evaluation of the quality of life of lupus erythematosus patients with cutaneous lesions in Japan
- The effect of a single epilation on successive hair eruptions in normal and hormone‐treated rats
- Itraconazole in the treatment of acute and recurrent vulvovaginal candidosis: comparison of a 1‐day and a 3‐day regimen
- Refractory alopecia in lupus treated with tofacitinib — a case-based review
- Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies
- Erythrokeratodermia Variabilis
- THERAPEUTIC APPROACHES TO THE MANAGEMENT OF COMMON BALDNESS
- What is new in therapeutics?
- New insights into microRNA in dermatological diseases
- Systemic Therapies for Scarring and Non-scarring Alopecia
- Eosinophilic Pustular Folliculitis Involving Labial Mucosa, Which Improved with Naproxen
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia